•
Sep 29, 2024

Qualcomm Q4 2024 Earnings Report

Qualcomm reported strong Q4 2024 results with significant EPS growth and advancements in key technology areas.

Key Takeaways

Qualcomm's Q4 2024 revenues reached $10.244 billion, a 19% increase year-over-year. GAAP EPS grew by 96% to $2.59, while non-GAAP EPS increased by 33% to $2.69. The company is focusing on growth and diversification initiatives, with strong performance in automotive and IoT sectors.

Qualcomm's Q4 revenues increased by 19% year-over-year, reaching $10.244 billion.

GAAP EPS grew by 96% to $2.59, and Non-GAAP EPS increased by 33% to $2.69.

QCT revenues increased by 18% year-over-year to $8.678 billion, driven by growth in handsets, automotive, and IoT.

The company returned $2.249 billion to stockholders through stock repurchases and dividends.

Total Revenue
$10.2B
Previous year: $8.67B
+18.2%
EPS
$2.69
Previous year: $2.02
+33.2%
Dividends Paid
$947M
Previous year: $893M
+6.0%
Shares Repurchase
$1.3B
Previous year: $400M
+225.5%
Gross Profit
$5.78B
Previous year: $4.75B
+21.6%
Cash and Equivalents
$7.85B
Previous year: $8.45B
-7.1%
Free Cash Flow
$2.39B
Total Assets
$55.2B
Previous year: $51B
+8.1%

Qualcomm

Qualcomm

Qualcomm Revenue by Segment

Forward Guidance

Qualcomm anticipates revenues between $10.5 billion and $11.3 billion for Q1 FY25, with QCT revenues expected to be between $9.0 billion and $9.6 billion, and QTL revenues between $1.45 billion and $1.65 billion. Non-GAAP diluted EPS is projected to be $2.85 - $3.05.

Positive Outlook

  • Revenue expected to be $10.5B - $11.3B
  • QCT revenues expected to be $9.0B - $9.6B
  • QTL revenues expected to be $1.45B - $1.65B
  • GAAP diluted EPS expected to be $2.39 - $2.59
  • Non-GAAP diluted EPS expected to be $2.85 - $3.05

Challenges Ahead

  • Outlook does not include provisions for proposed tax law changes.
  • Outlook does not include provisions for future asset impairments.
  • Outlook does not include provisions for pending legal matters.
  • Certain income and expense items cannot be accurately forecast.
  • Actual results may differ materially from the outlook.